Literature DB >> 17986490

Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland.

Catriona Matheson1, Christine M Bond, Michela Tinelli.   

Abstract

BACKGROUND: Community pharmacy contributes to drug misuse management and reduced spread of blood-borne disease through distributing clean needles and substitute drug dispensing. This paper reports a third Scotland-wide survey of pharmacies enabling service delivery to be charted over a decade.
METHODS: A cross-sectional postal questionnaire of all Scottish pharmacies (n=1166) was undertaken. Descriptive data were collected on services provided, attitudes, training and demography. Data were compared with data from 1995 and 2000.
RESULTS: Needle exchange provision increased slightly to 12.5% from 9.7% (2000) and 8.6% (1995). The mean number of needle exchange clients increased significantly to 37.7 from 20.3 (2000) and 12.5 (1995). Methadone was dispensed by 79.1% of respondents, and 90.9% of those supervised self-administration. The total number of methadone patients increased to 12 400 from 8809 in 2000 and 3387 in 1995. Of those taking methadone, 57% have supervised self-administration. A quarter dispensed buprenorphine to 190 patients. Attitudes improved significantly but training levels have not changed since 2000.
CONCLUSION: More commitment to harm reduction was evident through improved attitudes and increased services. Service delivery has increased more for dispensing services than for needle exchange. Strategies for delivering future needle exchange and substitute dispensing services are required if demand approaches capacity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986490     DOI: 10.1093/pubmed/fdm064

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  12 in total

Review 1.  Review of services provided by pharmacies that promote healthy living.

Authors:  David Brown; Jane Portlock; Paul Rutter
Journal:  Int J Clin Pharm       Date:  2012-04-17

2.  Management of drug misuse: an 8-year follow-up survey of Scottish GPs.

Authors:  Catriona Matheson; Terry Porteous; Edwin van Teijlingen; Christine Bond
Journal:  Br J Gen Pract       Date:  2010-07       Impact factor: 5.386

3.  Pharmacists and harm reduction: A review of current practices and attitudes.

Authors:  Tyler Watson; Christine Hughes
Journal:  Can Pharm J (Ott)       Date:  2012-05

4.  Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis.

Authors:  Aaron Salwan; Nicholas E Hagemeier; Fred Tudiver; KariLynn Dowling-McClay; Kelly N Foster; Jessie Arnold; Arsham Alamian; Robert P Pack
Journal:  J Am Pharm Assoc (2003)       Date:  2020-07-12

5.  Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): analyses using OD4 index in England and Scotland.

Authors:  John Strang; Wayne Hall; Matt Hickman; Sheila M Bird
Journal:  BMJ       Date:  2010-09-16

6.  Provision of opioid substitution therapy services in Australian pharmacies.

Authors:  B B Chaar; J R Hanrahan; C Day
Journal:  Australas Med J       Date:  2011-04-30

7.  Australian Community Pharmacy Harm-Minimisation Services: Scope for Service Expansion to Improve Healthcare Access.

Authors:  Sara S McMillan; Hidy Chan; Laetitia H Hattingh
Journal:  Pharmacy (Basel)       Date:  2021-04-26

Review 8.  Public health in community pharmacy: a systematic review of pharmacist and consumer views.

Authors:  Claire E Eades; Jill S Ferguson; Ronan E O'Carroll
Journal:  BMC Public Health       Date:  2011-07-21       Impact factor: 3.295

9.  Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.

Authors:  Li-Tzy Wu; William S John; Eric D Morse; Steve Adkins; Jennifer Pippin; Robert K Brooner; Robert P Schwartz
Journal:  Addiction       Date:  2021-08-16       Impact factor: 6.526

10.  Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

Authors:  Traci C Green; Emily F Dauria; Jeffrey Bratberg; Corey S Davis; Alexander Y Walley
Journal:  Harm Reduct J       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.